Beyond Air, Inc. (XAIR)
NASDAQ: XAIR · Real-Time Price · USD
1.090
-0.060 (-5.22%)
At close: Feb 4, 2026, 4:00 PM EST
1.090
0.00 (0.00%)
Pre-market: Feb 5, 2026, 5:12 AM EST
Beyond Air Revenue
Beyond Air had revenue of $1.82M in the quarter ending September 30, 2025, with 127.82% growth. This brings the company's revenue in the last twelve months to $5.80M, up 147.74% year-over-year. In the fiscal year ending March 31, 2025, Beyond Air had annual revenue of $3.71M.
Revenue (ttm)
$5.80M
Revenue Growth
+147.74%
P/S Ratio
0.95
Revenue / Employee
$95,115
Employees
61
Market Cap
11.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.71M | - | - |
| Dec 31, 2024 | 3.71M | 2.55M | 219.67% |
| Mar 31, 2024 | 1.16M | - | - |
| Dec 31, 2023 | 1.16M | - | - |
| Mar 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Mar 31, 2021 | 873.00K | - | - |
| Dec 31, 2020 | - | - | - |
| Mar 31, 2020 | 1.39M | - | - |
| Dec 31, 2019 | - | - | - |
| Mar 31, 2019 | 7.72M | - | - |
| Dec 31, 2018 | - | - | - |
| Mar 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Jun 30, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 48.57M |
| Lifeward | 24.50M |
| Vivos Therapeutics | 17.32M |
| Allurion Technologies | 17.21M |
| Intelligent Bio Solutions | 3.29M |
| Tenon Medical | 3.23M |
| Sintx Technologies | 1.27M |
| Movano | 500.00K |
XAIR News
- 8 days ago - Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 22 days ago - XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership - GlobeNewsWire
- 2 months ago - Beyond Air® Announces Transition of Chief Financial Officer - GlobeNewsWire
- 3 months ago - Beyond Air, Inc. (XAIR) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Beyond Air® Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference - GlobeNewsWire
- 5 months ago - Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds - GlobeNewsWire
- 5 months ago - Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire